Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Inflammatory mediators and NSAID effects, Cancer Immunotherapy and Biomarkers, and Chemokine receptors and signaling.
CCL21-DC tumor antigen vaccine augments anti-PD-1 therapy in lung cancer
Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis
Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by Downregulating Bmi‐1 Through Enhanced miR‐200c Expression
Phase I Trial of Intratumoral Injection of<i>CCL21</i>Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
GITR agonist enhances vaccination responses in lung cancer
Th17 cells in inflammation and autoimmunity
Quercetin attenuates doxorubicin cardiotoxicity by modulating <scp>B</scp> mi‐1 expression
The role of miRNA in inflammation and autoimmunity
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl
Myeloid Suppressor Cells and Immune Modulation in Lung Cancer
Targeting MDSCs enhance therapeutic vaccination responses against lung cancer